Group items matching

in title, tags, annotations or url

Intuit Quickbooks Remote Access takes You From the Grind to the Groove Picture this You're not stuck in a beige box on fluorescent Friday. Instead you're cruising down a vibrant boardwalk sun on your face ocean breeze in your hair and QuickBooks open on your tablet. Your fingers waltz across the screen sending invoices fluttering like colorful kites into the digital sky. No stuffy suits no soul-sucking commute just you your business and a vibrant rhythm of life. This my friend, is the sweet melody of remote QuickBooks access. Choose your soundtrack to financial freedom: Cloud Concerto: Embrace the boundless symphony of QuickBooks Online. Access your data from any device anywhere like a musical maestro conducting your finances from a rooftop café. Virtual Vault Vibe: Imagine your QuickBooks software serenading you from a secure cloud sanctuary. QuickBooks Hosting lets you access this harmonious haven remotely, like a financial alchemist unlocking the secrets of success from a sun-drenched mountaintop. Remote Bridge Rhythm: Think of these tools as trusty bongo drums connecting you to your office PC. With TeamViewer or Splashtop you're just a click away from bridging the gap opening QuickBooks from afar and drumming up some financial magic even if you're swaying to the beat by a bustling street market.

Recently launched generic version of Apixaban by Teva UK is said to bring savings to the NHS drug bill while making sure patients get the medicine they need. The generic apixaban is available for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA) and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults. Previously there was only a 'branded' product available, but Castleford-based Teva UK succeeded in invalidating the apixaban patent and SPC (supplementary protection certificate) in the UK High Court and so is now able to launch its own 'generic' version - which will bring savings for the NHS while making sure patients get the medicine they need. "We've always said that we stand up for the patient", said Kim Innes, General Manager of Teva UK and Ireland. "The launch of generic apixaban emphasises Teva's commitment to doing the right thing by putting patients at the heart of everything we do by giving them and the NHS access to affordable treatments." Apixaban is an anticoagulant which directly inhibits factor X (factor Xa), inhibiting thrombin formation and the development of thrombi (blood clots). For at-risk patients, such as those with, or at risk for DVT, or NVAF, the risk of stroke related to blood clots forming in the body and traveling to the brain is a serious concern. Each year, DVT affects around 1 person in every 1,000 in the UK and if left untreated, about 1 in 10 people with a DVT will develop a PE.

More than 5,000 vulnerable people have enrolled for the ground-breaking Platform Adaptive trial of NOvel antiviRals for eArly treatMent of Covid-19 In the Community (PANORAMIC) study on life-saving antivirals. With this the UK is now one step closer to rolling out the innovative medicines, which would help reduce the severity of symptoms and the risk of hospitalisation or death. Success of the study would eventually help to ease pressures on the NHS. Anyone over the age of 50 or between 18 to 49 with certain underlying health conditions can participate in the trial after receiving a positive PCR or lateral flow test result.